Children born in neighborhoods with fewer opportunities are more likely to experience repeated asthma flares requiring emergency care or medical treatment, with non-Hispanic Black children having the highest incidence rates ...
Apr 9, 2025
0
16
Steroid hormone levels in healthy adults are influenced by oral contraceptives and smoking, as well as other lifestyle choices and factors such as biological sex and age, according to new research that has just been published ...
Mar 28, 2025
0
27
A new study of more than 2,900 patients provides evidence that it's likely best to use as little corticosteroid medicine as possible when treating people who have lupus pericarditis, a common heart complication of the autoimmune ...
Feb 26, 2025
0
17
A study led by Aston University's Dr. Gemma Heath and Dr. Prasad Nagakumar from Birmingham Children's Hospital has shown that treatment and diagnosis for preschool wheeze requires more effective evidence-based guidelines. ...
Jan 13, 2025
0
19
Some maternal medications are associated with lower levels of protein and fat in breastmilk, according to a study published online Jan. 7 in JAMA Network Open.
Jan 10, 2025
0
13
An international, Phase III clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare disease that can cause debilitating symptoms. The study, published in the New England Journal of ...
Nov 14, 2024
0
18
A rare cause of hereditary cognitive decline known as CSF1R-Related Disorder (CSF1R-RD) gets its name from mutations in the CSF1R gene, discovered by Mayo Clinic. Memory loss occurs as the condition advances, while early ...
Sep 24, 2024
0
2600
Immune checkpoint inhibitors (ICIs) are a class of immunotherapy that have revolutionized the treatment of cancer. However, they can cause a wide variety of autoimmune toxicities, including immune checkpoint inhibitor-associated ...
Sep 6, 2024
0
40
The first-ever randomized study of the removal of the thymus gland in treating myasthenia gravis was conducted in 2016. Led by Gil I. Wolfe, MD, SUNY Distinguished Professor and the Irvin and Rosemary Smith Professor of Neurology ...
Jul 2, 2024
0
46
The U.S. Food and Drug Administration has approved the first generic version of Emflaza (deflazacort) oral suspension for Duchenne muscular dystrophy (DMD). Approval of the generic version of Emflaza oral suspension was granted ...
Jun 17, 2024
0
31
